ORGANIC
LETTERS
2000
Vol. 2, No. 18
2833-2836
Regioselective Synthesis of
1,3,5-Triaryl-4-alkylpyrazoles: Novel
Ligands for the Estrogen Receptor
Ying R. Huang and John A. Katzenellenbogen*
Department of Chemistry, UniVersity of Illinois, Urbana, Illinois 61801
Received June 27, 2000
ABSTRACT
A regioselective synthesis of 4-alkyl-1,3,5-triarylpyrazoles has been developed for the preparation of unsymmetrically substituted systems of
interest as ligands for the estrogen receptor.
In our efforts to discover novel ligands for the estrogen
receptor (ER) that might act as selective estrogen receptor
modifiers (SERMs),1 we found that 1,3,5-triaryl-4-alkylpyra-
zoles such as 1 and 2 (Scheme 1) were good ligands for
ER, demonstrating high binding affinities and transcriptional
efficacy that in some cases were very selective for the ER R
subtype (ERR).2,3 Initially, we synthesized these pyrazoles
by condensation of 2-alkyl-1,3-diketones with arylhydra-
zines.4-6 Of course, when the 1,3-diketones were unsym-
metrical, this approach did not afford any significant regio-
selectivity. This lack of regioselectivity became of concern
when we needed the corresponding monophenols 3 and 4
for structure-activity studies to determine which phenol in
pyrazole 2 mimics the A-ring of estradiol. According to a
classical approach, the monophenol with the higher affinity
can be presumed to be the one that corresponds to the A-ring
of estradiol.7,8 However, when the original 1,3-dione-
hydrazine condensation pyrazole synthesis was used to
prepare these monophenols, only an inseparable mixture of
the two regioisomers 3 and 4 was afforded (Scheme 1). Thus,
a regioselective approach to these and related compounds
was needed.
In a related effort, we wanted to develop these novel 1,3,5-
triaryl-4-alkylpyrazole ligands into the sort of mixed agonist/
antagonists that typically have SERM activity.9,10 This
generally involves incorporating a basic or polar side chain
(such as a piperidinylethoxy group) onto either the C(3) or
C(5) phenyl groups. However, when pyrazoles 6 and 7 were
prepared by condensation of 4-methoxyphenylhydrazine with
unsymmetrical 1,3-diketone 5, we obtained the regiosiomeric
pyrazoles 6 and 7 in pure form only after exhaustive
chromatography, and we had to obtain an X-ray structure of
the more crystalline isomer 6 to establish the identity of these
regioisomers (Scheme 1).
(1) Grese, T. A.; Dodge, J. A. Curr. Pharm. Des. 1998, 4, 71-92.
(2) Fink, B. E.; Mortensen, D. S.; Stauffer, S. R.; Aron, Z. D.;
Katzenellenbogen, J. A. Chem. Biol. 1999, 6, 205-219.
(3) Stauffer, S. R.; Katzenellenbogen J Comb. Chem. 2000, 2, 318-
329.
(4) Fink, B. E.; Mortensen, D. S.; Stauffer, S. R.; Aron, Z. D.;
Katzenellenbogen, J. A. Chem. Biol. 1999, 6, 205-219.
(5) Stauffer, S. R.; Coletta, C. J.; Tedesco, R.; Sun, J.; Katzenellenbogen,
B. S.; Katzenellenbogen, J. A. Submitted.
(6) Stauffer, S. R.; Huang, Y.; Coletta, C. J.; Tedesco, R.; Kazenellen-
bogen, J. A. Bioorg. Med. Chem. In press.
(7) Anstead, G. M.; Carlson, K. E.; Katzenellenbogen, J. A. Steroids
1997, 62, 268-303.
The results from cell-based transcriptional assays showed
that pyrazole 7 has the desired antagonistic character typical
for a SERM. However, to examine this series further we
(8) Anstead, G. M.; Peterson, C. S.; Katzenellenbogen, J. A. J. Steroid
Biochem. 1989, 33, 877-887.
(9) Grese, T. A.; Dodge, J. A. Curr. Pharm. Des. 1998, 4, 71-92.
(10) Magarian, R. A.; Overacre, L. B.; Singh, S.; Meyer, K. L. Curr.
Med. Chem. 1994, 1, 61-104.
10.1021/ol0062650 CCC: $19.00 © 2000 American Chemical Society
Published on Web 08/16/2000